StockData
Dare Bioscience, Inc. logo

Dare Bioscience, Inc. (DARE) stock

DARENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$0.43−0.16 (-26.57%)

Close on Nov 17, 2026Market cap $6.56MP/E –Yield –

Dare Bioscience price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Dare Bioscience's price to sales ratio was 7.7× on Nov 11, 2026, against 127.5× a year earlier. Over the last 3 years it ranged from 6.4× to 150.6×, with a median of 14.2×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20267.7×−7.1
2025Jan 31, 202514.8×+0.6
2024Dec 31, 202414.2×−16.2
2023Dec 29, 202330.4×+23.8
2017Apr 28, 20176.6×–

More Dare Bioscience figures

See a number that looks wrong?